Angioshield

DEVICE2 trials

Sponsors

Neograft Technologies, Incorporated

Conditions

Coronary Artery Disease

Unknown Phase

Angioshield First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy

CompletedNCT02072239

Neograft Technologies, IncorporatedCoronary Artery Disease

Start: 2014-02-28End: 2015-07-31Updated: 2017-01-13

The Angioshield Study Feasibility II

CompletedNCT02543047

Neograft Technologies, IncorporatedCoronary Artery Disease

Start: 2015-11-30End: 2018-03-07Updated: 2018-05-25